Abstract
MiR-502 is the first reported miRNA targeting simultaneously classical non-homologous end joining (NHEJ) and the cell cycle response
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/j.pan.2018.05.321
Journal: Pancreatology | Publication Date: Jun 1, 2018 |
MiR-502 is the first reported miRNA targeting simultaneously classical non-homologous end joining (NHEJ) and the cell cycle response
Join us for a 30 min session where you can share your feedback and ask us any queries you have